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Abstract
We previously reported that preculture of fibroblasts (FBs) and endothelial cells (ECs) prior to
cardiomyocytes (CMs) improved the structural and functional properties of engineered cardiac
tissue compared to culture of CMs alone or co-culture of all three cell types. However, these
approaches did not result in formation of capillary-like cords, which are precursors to
vascularization in vivo. Here we hypothesized that seeding the ECs first on Matrigel and then
FBs 24 h later to stabilize the endothelial network (sequential preculture) would enhance cord
formation in engineered cardiac organoids. Three sequential preculture groups were tested by
seeding ECs (D4T line) at 8%, 15% and 31% of the total cell number on Matrigel-coated
microchannels and incubating for 24 h. Cardiac FBs were then seeded (32%, 25% and 9% of
the total cell number, respectively) and incubated an additional 24 h. Finally, neonatal rat CMs
(60% of the total cell number) were added and the organoids were cultivated for seven days.
Within 24 h, the 8% EC group formed elongated cords which eventually developed into
beating cylindrical organoids, while the 15% and 31% EC groups proliferated into flat EC
monolayers with poor viability. Excitation threshold (ET) in the 8% EC group (3.4 ±
1.2 V cm−1) was comparable to that of the CM group (3.3 ± 1.4 V cm−1). The ET worsened
with increasing EC seeding density (15% EC: 4.4 ± 1.5 V cm−1; 31% EC: 4.9 ±
1.5 V cm−1). Thus, sequential preculture promoted vascular cord formation and enhanced
architecture and function of engineered heart tissues.
S Online supplementary data available from stacks.iop.org/BF/4/035002/mmedia
(Some figures may appear in colour only in the online journal)
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1. Introduction
The goal of cardiac tissue engineering is to build heart tissues
that can serve as models for pathophysiological discovery
or as functional replacements for damaged myocardium.
The engineered tissues should thus not only resemble the
structure of native myocardium, but also be vascularized to
enable proper oxygenation and integration with the blood
supply of the host.
Cardiac tissue consists of three major cell types:
cardiomyocytes (CMs), which compose about a third of the
total cell mixture, and the non-myocytes (fibroblasts, FBs
and endothelial cells, ECs), which make up the remainder.
CMs are responsible for generating contractile force (Banerjee
et al 2006, Nag 1980) while FBs secrete extracellular matrix
(ECM) proteins and paracrine factors (Banerjee et al 2006,
Kuzuya and Kinsella 1994). ECs line coronary vasculature to
provide a barrier to thrombus formation and can form capillary
tubes which are precursors to neovascularization (Seghezzi
et al 1998). A host of other non-myocyte cell types also
exist in the heart including erythrocytes, leukocytes, smooth
muscle cells and pericytes (Banerjee et al 2006, Nag 1980),
though in much smaller numbers. Pericytes are responsible for
stabilizing capillary sprouts in vivo through the deposition of
perivascular ECM components (Armulik et al 2005, von Tell
et al 2006), and it was recently suggested that these pericytes
may express many of the same markers as mesenchymal stem
cells (MSCs) (Crisan et al 2008). Initial attempts at cardiac
tissue engineering tended to remove non-myocytes from heart
cell isolates (Bursac et al 1999), whereas recent work shows
that their inclusion can enhance the function of engineered
tissue (Caspi et al 2007, Iyer et al 2009a, Levenberg et al
2005, Naito et al 2006).
We previously showed that pre-culturing EC and FB in
microchannels for two days prior to seeding CM (termed
‘preculture’) resulted in beating cardiac organoids resembling
native myofibers (Iyer et al 2009a). These organoids
displayed superior functional and structural properties to
organoids engineered using purified CMs (‘enriched CMs’)
or organoids engineered by mixing all three cell types
(‘simultaneous tri-culture’) (Iyer et al 2009a). However, ECs
within the precultured organoids did not organize themselves
into capillary-like structures, and instead were found evenly
distributed throughout the tissue (Iyer et al 2009a, 2009b). This
was surprising, since human umbilical vein endothelial cells
(HUVEC) and human dermal microvascular endothelial cells
(HMVEC) grown on collagen gels in 3D have been shown
to form capillary-like sprouts (Matsumoto et al 2007, Nor
et al 1999, Wright et al 2002). Human embryonic stem-cell
(hESC)-derived ECs have been shown to spontaneously form
cords when seeded on Matrigel (Levenberg et al 2002). The
formation of these capillary sprouts by ECs is a key step toward
neovascularization (Seghezzi et al 1998), which motivated us
to further explore if we could enhance cord formation in our
engineered tissues.
We hypothesized that seeding FBs 24 h after ECs would
stabilize the immature sprouts formed by ECs, and that
these stabilized vascular networks would result in improved
functional properties of engineered cardiac tissue. To test this
hypothesis, we sequentially cultured ECs to allow vascular
sprouting to occur, followed by FBs 24 h later to aid in
stabilization of the cords by deposition of perivascular matrix
(Armulik et al 2005, Levenberg et al 2005, von Tell et al 2006).
We tested the effect of EC number (8%, 15% and 31% of the
total cell number) on cord formation, to determine the optimal
percentage of ECs for engineering cardiac tissues containing
stable vascular cords. We made use of microfabricated
poly(ethylene glycol) (PEG) channels to answer this question
using microtissues. Thus, microfabrication enabled us to
efficiently use cells and culture media compared to the regular
mm-scale tissue culture.
2. Methods
2.1. Microfabrication and sterilization of PEG templates
The technique for PEG template microfabrication has been
previously described (Iyer et al 2009a). Briefly, liquid PEG
diacrylate monomer was mixed with 0.5% v/v hydroxy
methyl propiophenone photoinitiator (HMPP, Sigma) to create
a pre-polymer solution. The pre-polymer was crosslinked
around a polypropylene mesh (used as a master for the
microchannels) by exposure to a UVB light source (UVL-21,
ultraviolet products) for 30 s at a distance of 1 cm
through a circular mask, resulting in PEG discs patterned
with three-dimensional microchannels of 100–200 μm in
diameter and 3–4 mm in length. The discs were sterilized
then soaked in CM/FB medium (composition described in
section 2.2.1) for 24–48 h. Discs were coated with
Matrigel R©matrix (Beckton–Dickinson) and placed in 96-well
titer dishes at 4 ◦C for 24 h (see supplemental figure 1 available
at stacks.iop.org/BF/4/035002/mmedia). The discs were then
placed at 37 ◦C for 1 h prior to cell seeding to allow the
Matrigel R© to undergo gelation.
2.2. Cells
2.2.1. Neonatal rat heart cell isolation. The procedure
for neonatal rat heart cell isolation is described extensively
in our previous work (Radisic et al 2003, 2004a, 2004b,
2006). Briefly, neonatal (1–2 day-old) Sprague-Dawley rats
were euthanized according to the procedure approved by the
University of Toronto Committee on Animal Care. The hearts
were quartered and the cells were isolated by serial enzymatic
digest. The supernatant was collected and centrifuged at low
speed (750 RPM or 94 × g, to remove red blood cell
contamination) for 4 min. The resulting cell suspension was
either resuspended in culture medium and pre-plated into T75
flasks for two 1 h intervals to separate the non-adherent cells
(enriched CM) from the adherent cells (non-myocytes), or
was used directly as a whole heart isolate (see supplemental
figure 1 available at stacks.iop.org/BF/4/035002/mmedia and
section 2.3.1). Primary cardiac FBs used in experiments were
obtained by passaging the cells adhered to the T75 flask during
the pre-plating step. The CM and FB were cultured in the same
medium, termed ‘CM/FB medium’, consisting of Dulbecco’s
modified eagle medium (DMEM) with 4.5 g L−1 glucose,
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Table 1. Percentages of cells seeded in the sequential preculture experiments.
Group EC (applied at 0 h) FB (applied after 24 h) Enriched CM (applied at 48 h)
Sequential preculture 8% 8% (16 × 103) 32% (64 × 103) 60% (1.2 × 105)
Sequential preculture 15% 15% (31 × 103) 25% (49 × 103) 60% (1.2 × 105)
Sequential preculture 31% 31% (62 × 103) 9% (18 × 103) 60% (1.2 × 105)
4 mM L-glutamine, 10% certified fetal bovine serum (FBS),
100 U mL−1 penicillin, 100 μg mL−1 streptomycin, and
10 mM 4–2-hydroxyethyl-1-piperazineethanesulfonic acid
buffer (HEPES, Gibco/Invitrogen).
2.2.2. Cell lines. D4T ECs (kind gift of P Zandstra), an
embryoid body-derived mouse EC line (Choi et al 1998),
were maintained in EC medium consisting of Iscove’s
modified Dulbecco’s medium (IMDM), 5% certified FBS,
100 U mL−1 penicillin, and 100 μg mL−1 streptomycin
(Gibco/Invitrogen). Cells were passaged at 70% confluence
every 5–7 days.
2.3. Experimental design
2.3.1. Modulating EC seeding density. For sequential
preculture organoids (supplemental figure 1(A) available at
stacks.iop.org/BF/4/035002/mmedia), the total cell number
seeded was 2 × 105 cells per PEG disc as in our previous
studies (Iyer et al 2009a, 2009b). ECs were seeded first
(to enable cord formation), followed by seeding of FBs 24 h
later (to enable cord stabilization through ECM deposition),
and enriched CMs 48 h later (to form cardiac tissue). The
fraction of CMs was fixed at 60%, as determined to be
favorable for organoid formation in our previous studies
(Iyer et al 2009b). The fractions of ECs and FBs in the
remaining 40% of non-myocytes were varied, to form three
experimental groups: (i) 8% ECs + 32% FBs, (ii) 15%
ECs + 25% FBs and (iii) 31% of ECs + 9% of FBs. In
all groups, the total number of CMs, ECs and FBs was
maintained at 2 × 105 cells disc−1. Organoids based on
enriched CMs (supplemental figure 1(B)) and the whole
heart cell isolates (supplemental figure 1(C), both available at
stacks.iop.org/BF/4/035002/mmedia) served as controls. The
experimental design is described in supplemental figure 1
(available at stacks.iop.org/BF/4/035002/mmedia) and table 1.
2.4. Assessments
2.4.1. Live/dead staining. Live/dead staining was performed
as previously described (Iyer et al 2009a). Briefly, the PEG
discs were incubated in a solution of propidium iodide and
carboxyfluorescein diacetate-succinimidyl ester for 30–45 min
at 37 ◦C. As a result, non-viable cell nuclei were labeled red
while viable cell cytoplasms were labeled green. The tissues
were imaged on a fluorescence microscope (Leica DMIRE2).
2.4.2. Cryosectioning and immunofluorescence. For
immunostaining, organoids were cryosectioned and
immunostained as described previously (Iyer et al 2009a).
Briefly, discs were fixed in 4% paraformaldehyde (PFA) for
1 h and immersed in a 30% w/v solution of sucrose for 1–2 h.
The discs were placed face down in cryomolds, embedded
in O.C.T. medium, and snap frozen in liquid nitrogen for
30 s. The discs were stored at –80 ◦C for at least 1 h before
cryosectioning in a cryostat operating at an ambient and
specimen temperature of −24 ◦C. 10 μm thick face sections
were mounted on positively charged specimen slides (VWR)
and stored at −20 ◦C for 24 h. The specimens were thawed
at room temperature, fixed in acetone, and again air dried
before blocking with 10% normal goat serum (NGS) or
normal horse serum (NHS) in PBS and stained with primary
antibodies (at 4 ◦C for 24–48 h) and secondary antibodies
(at room temperature for 1 h). Primary antibodies included
rabbit or mouse anti-cardiac troponin I (Chemicon, 1:150),
rabbit anti-PECAM-1/CD31 (Abcam, 1:50), and mouse
anti-vimentin-Cy3 (Sigma, 1:50). FITC-conjugated goat
anti-rabbit (Vector Laboratories, 1:100) or goat anti-mouse
antibody was used as a secondary antibody for troponin
I and CD31. DAPI was used as a nuclear counterstain
(final concentration of 1 μg mL−1) and was added to the
secondary antibody solution. A drop of mounting medium
was added to the specimen and a glass coverslip was placed
on top.
Fluorescence microscopy was carried out on an inverted
fluorescence microscope (Olympus America, Model # IX81)
controlled by QED Imaging In Vitro Software version 3.1.0
(Media Cybernetics Inc.). Cell fractions were determined
by manual counting, which was performed by two blinded,
independent observers. Numbers of CMs, non-myocytes, or
ECs were determined by counting the number of troponin
I-positive, vimentin-positive, or CD31-positive cells in each
fluorescence image. These were normalized to the total cell
number per image, as determined by DAPI counterstaining,
and plotted as average percentages over several images.
Elongation of CMs was determined by measuring the aspect
ratio (the ratio of cell length to cell width) of troponin I-positive
cells (n = 5 images/group). The analysis was done by drawing
lines on the axes of the cells and measuring the length of the
line by ImageJ.
2.4.3. Cell tracking. Endothelial cells were fluorescently
labeled to facilitate cell tracking of cords, as previously
described (Iyer et al 2009b). Briefly, ECs were incubated
for 30 min at 37 ◦C and 5% CO2 in a 5 μM solution
of CellTrackerTM Red CMPTX (Molecular Probes Cat.
no C34552) made up in serum-free medium. The cells
were centrifuged and washed twice prior to seeding in
microchannels. The organoids were imaged by fluorescence
microscopy at 24 h (prior to FB seeding) and 48 h (after FB
seeding) to monitor the presence and morphology of vascular
cords.
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(A)
(B)
Figure 1. EC cord formation is dependent on the percentage of ECs in sequential preculture (phase contrast). Sequential preculture
containing 8% ECs (sequential preculture 8%) was performed to allow for capillary cord formation by ECs. The enriched CM fraction was
kept constant at the percentage determined most beneficial for regular pre-culture in previous studies (60% enriched CM) and the EC
seeding percentage was varied from 8% to 31%. (A) Phase contrast microscopy at 24 h following EC seeding. Sequential preculture 8%
group displayed evidence of cords (white arrows) while the other groups showed EC proliferation into flat cell layers. (B) Phase contrast,
microscopy after seven days of cultivation. Cardiac FB and enriched CM were added at 24 and 48 h following EC seeding, respectively, and
the organoids were cultivated for seven additional days. Sequential preculture 8% formed cylindrical organoids (white arrows) with overall
elongated cell morphology, while the other groups remained as two-dimensional cell layers consisting of rounded cells. Enriched CMs also
appeared mostly rounded. n = 3–5 samples per group.
2.4.4. Functional properties. Contractile function of cardiac
organoids was measured using either an S88X or an S48 grass
stimulator (Grass Technologies/Astro-Med Inc) as described
previously (Iyer et al 2009a, Radisic et al 2004a). Briefly, the
excitation threshold (ET, measured in V cm−1) of the tissues
was determined by subjecting the tissues to monophasic,
square pulses of 2 ms pulse width and measuring the
minimum amplitude at which synchronous contractions could
be observed. Maximum capture rate (MCR, measured in Hz)
was determined at 200% of ET by measuring the maximum
frequency of synchronized contractions. Thus, a lower ET and
higher MCR implied a more electrically responsive tissue.
If the organoids could not be excited by an electric field
strength of up to 10 V cm−1, they were deemed as non-beating
(denoted n/a). We also quantified the success rate, defined as
the ratio of the number of beating samples to the total number
of samples tested for contractile function. A success rate of
1.0 implied all tested samples could be induced to contract,
while a value less than 1.0 implied fewer samples were able to
contract.
2.4.5. Statistics and data representation. Results are
presented as means ± standard deviation. Statistically
significant differences, unless otherwise indicated, are denoted
with horizontal bars. All statistical calculations were
performed using SigmaStat 3.0 (SPSS Inc). One-way ANOVA
in conjunction with the Holm–Sidak posthoc test was used to
compare three or more groups or two groups versus control
while t-test was used for pairwise comparisons. Normality of
data and equality of variance were checked for all comparisons.
Where normality failed, one-way ANOVA on ranks was
performed using a Mann–Whitney test. Where equality of
variance failed, ANOVA on ranks in conjunction with Dunn’s
test and multiple pairwise comparisons was performed. A
p-value < 0.05 was considered statistically significant for all
tests. Sample numbers were n = 3–5 biological replicates for
all analyses. For cell number/viability quantitation and image
analyses, data were pooled from n = 3–5 biological samples,
and n = 9–12 pooled images were counted and analyzed from
a representative set of images for each sample.
3. Results and discussion
3.1. The 8% EC group yielded beating organoids with
vascular-like cords
We tested the hypothesis that sequential preculture of ECs
prior to FBs and CMs would enable the formation of vascular
cords in cardiac organoids. To this end, different numbers
of ECs (table 1) were first seeded on Matrigel-coated PEG
microchannels to allow for capillary-like sprouts to form
within 24 h, as previously reported (Levenberg et al 2002,
Wright et al 2002). The two EC densities at the lower end
of the spectrum (8% and 15%) were chosen because they
were in agreement with seeding densities previously reported
to support cord formation (Levenberg et al 2002, Matsumoto
et al 2007, Nor et al 1999, Wright et al 2002). The value of
31% ECs served as an effective control for comparison to our
previous studies (Iyer et al 2009b).
We have previously conducted culture medium screen
assays to compare the effects of EC medium (IMDM + 5%
FBS + 1% pen/strep) with those of CM/FB medium
(DMEM + 10% FBS + 1% HEPES + 1% pen/strep) on
cell viability, density and proliferation. These medium screen
data are published in our previous work (Iyer et al 2009a), and
we have shown that there were no significant differences in
proliferation, cell density, or cell viability when ECs were
grown in EC medium versus CM/FB medium (Iyer et al
2009a). Thus, we chose the CM/FB medium for the tri-culture
studies.
As shown in phase contrast micrographs (figure 1(A)), we
observed marked differences in morphology among the groups
4
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Figure 2. Cell tracking on cords demonstrates persistence of EC cords after FB seeding in the sequential preculture 8% group. Primary ECs
were incubated with CellTracker Red and grown for 24 h on Matrigel R©-coated microchannels to allow for cord formation. Primary cardiac
FBs were then seeded and the cords were grown for an additional 24 h. At 48 h cords were imaged under both fluorescence and phase
contrast microscopy. Cords formed in the sequential preculture 8% group after 24 h, whereas the ECs proliferated into flat monolayers at all
other seeding densities (top row). After seeding the FBs, the cords appear to be stabilized in the sequential preculture 8% group. In the 15%
and 31% groups, CellTracker Red-labeled ECs are found scattered throughout the structure (scale bar: 50 μm). n = 3–5 samples per group.
at 24 h after seeding the ECs on Matrigel. As hypothesized,
ECs formed cords on Matrigel prior to the addition of
FBs, and the 8% EC group was the only group which
showed evidence of capillary cord-like sprouts that eventually
integrated into healthy cardiac organoids resembling cardiac
myofibres (figure 1(A), white arrows). In the groups with
higher EC seeding densities, most of the cells had proliferated
into flat cell layers. Figure 1(B) shows phase contrast images of
the cardiac organoids on day 7 of cultivation after adding FB
and CM. The 8% EC group also formed three-dimensional
organoids (white arrows) characterized by elongated cells
while the higher EC seeding percentage groups (15% ECs,
31% ECs) remained as a flat layer of cells. As the EC seeding
percentage increased we noted fewer spontaneous contractions
on day 7 and a higher number of rounded cells.
3.2. Cords are stabilized over 48 h in the 8% EC group
We further investigated whether the cords retained their
structure after seeding the FBs. This was assessed by
performing cell tracking on the EC cords by labeling the ECs
with a CellTracker red dye prior to seeding. As shown in
figure 2, the cords in the 8% EC group retained their cord-like
organization even after FBs were seeded and did not proliferate
into EC monolayers. This was in contrast to the 15% and 31%
EC groups, where flat monolayers of cells were visible at 48 h
(figure 2, red labeled cells).
3.3. Morphology and viability of the 8% EC group organoids
resemble organoids grown using whole heart cell isolates
Live/dead staining performed at day 7 on the sequential
preculture groups (figure 3), seeded with varying EC percent-
ages (8%, 15% and 31%), showed similar morphological fea-
tures to phase contrast microscopy and cell tracking studies
(figures 1 and 2). We also performed live/dead staining on
organoids engineered using CMs and the whole heart isolate
as a baseline condition (figure 3). Due to the non-specific na-
ture of live–dead staining (figure 3), it was not possible to
determine exactly the phenotypes of necrotic cells. The 8%
EC group which formed the cords was also the group which
formed the most viable cardiac organoids. In contrast, the
other groups showed marked areas of rounded cells, and the
integrity of the organoids became more fragmented as the EC
seeding percentage increased to 31%. The majority of cells in
the 8% EC cord-forming group showed high viability (figure 3,
green cells showing CFDA expression). However, as the EC
seeding density increased to 31%, the number of dead cells
(figure 3, nuclei stained red with propidium iodide) increased
and became comparable to the CM group, which displayed
the greatest amount of cell death (figure 3, red stained nuclei).
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Figure 3. Viability of sequential preculture is the highest in the 8% group. Organoids were stained with CFDA-SE (green) and propidium
iodide (red) to label live cells and dead cell nuclei, respectively, after seven days of sequential preculture. The group which formed cords
(8%) had the fewest number of dead cells and the highest cell viability as well as elongated organoids densely populated with cells. Viability
appeared to decrease with increasing EC density and was lowest in the enriched CM group. Higher magnification images for the sequential
preculture 8% and whole heart isolate groups showed similar cell morphology in the two groups. n = 3–5 samples per group.
Cells in the whole heart isolate group formed fibrillar struc-
tures which appeared elongated, viable and healthy, and bore
a very similar morphology to the 8% EC group which also
contained vascular-like cords (figure 3, right panel).
3.4. Elongation of troponin I-positive cells is most prevalent
in the 8% EC and whole heart isolate groups
Immunostaining (figure 4(A)) for troponin I (TnI), vimentin
(Vim) and CD31 was performed in all groups to provide
information on the cell composition of organoids at day 7
of cultivation, using CM organoids and whole heart isolate
organoids as baseline controls. The 8% EC group formed the
most elongated organoids with a compact arrangement of cells
as compared to the 15% and 31% EC groups where the cell
density appeared sparse. The presence of cardiac marker TnI
was markedly more abundant in the 8% EC group, CM group
and the whole heart isolate group. Notably, the TnI-positive
cells were most elongated in the 8% EC and whole heart
isolate groups (figure 4(F), P < 0.0001 one-way ANOVA).
The cell density was overall highest in the enriched CM
group and comparable among the sequential preculture 8% and
whole heart groups, while cell densities were overall lowest in
the 15% and 31% sequential preculture groups (figure 4(G),
P < 0.05 ANOVA on ranks). Commensurate with the lower
number of TnI-positive cells and higher numbers of ECs in the
15% and 31% EC groups, there were also more non-myocytes
(Vim-positive cells) in these groups. Meanwhile the presence
of Vim was lower in the 8% EC group, the CM group, and the
whole heart isolate group as compared to the 15% and 31%
EC groups.
We expected the higher TnI presence and lower Vim
presence in the CM group since we have previously reported
that the percentage of CMs after two preplating steps was
81% ± 14%, as determined by analytical flow cytometry
(Iyer et al 2009a). Since these cells are derived from a
primary source, consisting of a heterogeneous population, the
purity of CMs used in the present study is consistent with
previous results (Naito et al 2006). CD31 staining (figure 4(B))
correlated well with the percentages of ECs, with an increase in
EC seeding percentage correlating to an increase in the number
of CD31-positive cells on day 7. The 8% EC group and the
CM group also displayed lower percentages of CD31-positive
cells as compared to the 15% and 31% EC groups. Overall,
we noted that, qualitatively, the cell density, distribution of
TnI-positive, Vim-positive, and CD31-positive cells, and cell
elongation were most similar between the 8% EC group which
formed cords and the whole heart cell isolate group.
As shown in figure 4(C), the percentage of CM on day 7,
as expected, was the highest in the CM group (∼70%). This
high value was expected since the enriched CMs contain
81% ± 14% TnI-positive cells after two preplating steps
(Iyer et al 2009a), and the fraction of CMs decreases with
time due to proliferation of non-myocytes and some CM
death. The percentage of CMs was maintained at day 7
in 8% EC and 31% EC groups, but not in the 15% EC
group (figure 4(C)). Interestingly, organoids engineered from
the whole heart isolate also attained a final percentage of
∼60% CMs, similar to the 8% and 31% EC groups.
As expected, the trends in the percentage of Vim-positive
cells (figure 4(D)) were exactly the inverse of the trends seen
in the TnI-positive cells. The 15% EC and 31% EC groups
contained 50–70% non-myocytes after seven days of culture,
presumably due to proliferation of non-myocytes. The CM
group, 8% EC group, and the whole heart isolate group all
6




































































































Figure 4. Immunofluorescence microscopy for Troponin-I, Vimentin, and CD31 in sequential preculture. Immunofluorescence data were
obtained from frozen sections of organoids in order to assess phenotype, cell distribution and tissue morphology. (A) Troponin-I (green) was
used to label cardiomyocytes and Vimentin (red) was used to label non-myocytes (fibroblasts and endothelial cells collectively). (B) Staining
for CD31 was used to image endothelial cells independently. DAPI (blue) was used as a counterstain for cell nuclei in all images. Troponin I
presence appeared highest in the group which formed cords (8%), while Vimentin presence increased as the EC seeding percentage
increased. Organoids were overall more elongated in the group with the cords and similar in morphology to the whole heart isolate group
(see high magnification insets). (C)–(E) Manual counting of images was performed to assess the relative contribution of each cell type to the
final cellular composition of the organoids. Percentages of (C) Troponin I-positive, (D) Vimentin-positive and (E) CD31-positive cells.
(C) The percentage of Troponin I-positive cells was high in the sequential preculture 8% group which formed cords, the enriched CM group
and the whole heart isolate group, and was lowest in the sequential preculture 15% and sequential preculture 31% groups. (D) The opposite
trend was seen in the Vimentin-positive percentages, with lower non-myocyte percentages in the sequential preculture 8% group, enriched
CM group, and whole heart isolate group compared to high percentages in the sequential preculture 15% and sequential preculture 31%
groups, suggesting non-myocyte proliferation and/or possible myocyte death in these groups. (E) The CD31-positive fraction was in the
range from 5% to 10% in the sequential preculture 8%, sequential preculture 15%, and whole heart isolate groups, but nearly double in the
sequential preculture 31% and enriched CM groups. n = 3–5 samples per group for experimental samples, n = 9–11 images counted per
group. (F) Aspect ratio of Troponin I-positive cells showed more elongated cardiomyocytes in the sequential preculture 8% and whole heart
isolate groups (n = 5 images counted per group). (G) High cell density was found in the sequential preculture 8%, enriched CM and whole
heart isolate groups.
attained similar final percentages of non-myocytes (between
30% and 40%).
To determine the endothelial contribution to the non-
myocyte percentages, the number of CD31-positive cells was
also quantified from immunofluorescence data (figure 4(E)).
In all sequential preculture groups, the final percentages of
ECs on day 7 increased with increasing the seeding number
of ECs, as expected. The final percentages of CD31-positive
cells were similar (between 5% and 10%) in the 8% EC,
15% EC, and whole heart isolate groups, but were higher
(around 20%) in the 31% EC and CM groups. Considering
that the percentages of Vim-positive cells were higher than
the percentages of CD31-positive cells, it is likely that the
majority of non-myocytes present in the organoids were FBs
and that the FBs were also primarily responsible for any non-
myocyte proliferation that may have taken place. As with the
TnI and Vim positive cells, the 8% EC group and the whole
heart isolate group had similar numbers of CD31-positive cells,
7
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Figure 5. Functional properties of sequential preculture. (A) Excitation threshold (ET). (B) Maximum capture rate (MCR). Functional
properties were measured for sequential preculture organoids by varying the electric field strength and frequency of stimulation. The ET was
found to be lowest in the sequential preculture 8% group with the cords and the whole heart isolate group. MCRs, however, were highest in
the enriched CM group and the whole heart isolate group, and comparable among all of the sequential preculture groups. n = 3–5 samples
per group.
and appeared similar in terms of myocyte and non-myocyte
composition. Aspect ratios of TnI-positive cells (figure 4(F))
were highest in the 8% EC and whole heart isolate groups
(∼6) compared to the other groups (∼2–3). Cell densities
(figure 4(G)) were also highest in these two groups as well
as the enriched CM group (∼1000 cells/mm2) compared with
the other groups where cell densities were less than half of
this number (∼300–500 cells/mm2), in line with qualitative
observations.
3.5. Excitation threshold is lowest in the 8% EC group and
increases with EC seeding percentage, while MCR is
comparable among all sequential preculture groups
Functional data were obtained by measuring the ET
(figure 5(A)) and MCR (figure 5(B)) of the organoids grown
for seven days. The ET was best (lowest) in the 8% EC group
and tended to increase as the EC seeding percentage increased
(figure 5(A)). For the 8% EC group, the ET was 3.4 V cm−1,
which was comparable to the CM group (3.3 V cm−1), and
lower than both the 15% (4.4 V cm−1) and the 31% EC group
(4.9 V cm−1). All of the sequential preculture groups had
comparable MCRs (∼4 Hz). However, the group with the
highest MCR was the CM group (6.4 Hz).
We also noted that the success rate of beating samples
was highest (1.0) in the sequential preculture 8% group and
the enriched CM group, where all samples could be induced
to contract in the presence of an electric field. However in the
15% and 31% EC groups, the success rates were 0.7 and 0.8,
respectively, suggesting poorer overall functional properties in
these groups.
The use of sequential preculture containing 8% ECs
presents a possible strategy for improving the structural
organization and functional outcome of engineered heart
tissue by enabling vascular-sprouting and stabilization. Our
data indicate that the cell population consisting of 8% ECs,
32% FBs and 60% CMs supports both the formation of
vascular cords and establishment of contractile function. Since
increasing the EC seeding density above 8% worsened both the
cell viability and functional properties (ET) of the organoids,
this EC percentage may represent an upper limit beyond which
functionality and viability may be compromised due to EC
overgrowth and CM death.
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Despite the success of the 8% EC group, the MCR was
still higher in the CM and whole heart isolate groups. The
whole heart isolate, in particular, represented a physiological
mixture of cells where the cellular percentages present in the
heart were not modified in any way. In effect, this was an
excellent baseline condition for our studies, the one we were
seeking to emulate through the use of sequential preculture so
that the cellular composition and organization would mimic
that of the native heart.
We used microfabricated substrates to facilitate the
optimization of cell culture conditions that would require
significant cell and culture media resources if performed on
a mm-scale. Here we provide feasibility data, demonstrating
that the results of the microscale studies can be scaled-up
to mm-sized constructs. Scale-up of preculture conditions
from microtemplate studies was possible by volumetrically
scaling up the amount of Matrigel and cells in the 8% group
used in 100 μm diameter microchannels and applying this
to the macroscale geometry of a cylindrical collagen sponge
of 2 mm height, 7 mm diameter. ECs were seeded first,
followed by FB 24 h later and CM 48 h later resulting
in a beating cardiac construct after nine days in culture
(supplemental figure 2 and supplemental video 1, available at
stacks.iop.org/BF/4/035002/mmedia). Further detailed studies
of the mm-scale tissue properties are a subject of future
work.
A confounding factor with the use of primary cells for
cardiac tissue engineering is that the precise ratios of cells in
the whole heart isolate can vary depending on the isolation
conditions and viability of the starting population. Thus, we
believe that the 8% EC group, which has defined seeding
percentages of ECs, FBs and CMs, and allows for cord
formation and stabilization, represents a better strategy for
cardiac tissue engineering studies and is easily amenable to
non-primary cell sources as well. As an example, the optimized
cell percentages arrived at in this study (that is, 8% ECs,
32% FBs, and 60% CMs) combined with sequential preculture
could be applied to hESC-derived or induced pluripotent stem
cell-derived ECs, FBs, and CMs and employed in engineering
pre-vascularized, human, patient-specific heart tissues with
properties similar to those in the native heart. Such an
engineered heart tissue could provide a physiological-like
heart tissue model for drug development and disease modeling
studies as well as a source of engineered cardiac patches for
patient therapy.
Upon enzymatic isolation, the native heart isolate contains
∼47% CM, 49% FB, 2–3% EC and 2–3% smooth muscle
cells (Naito et al 2006). After one pre-plating step the
suspension contains ∼63% CM, 33% FB, ∼3% EC and ∼3%
smooth muscle cells as we and others have reported (Brown
et al 2008, Iyer et al 2009a, Naito et al 2006). One more
pre-plating step enriches the CMs to 81% ± 14% at the
expense of FB while EC and smooth muscle cell percentage
remains largely unaffected. In the enriched CM group and
the whole heart group, the formation of vascular cords was
not observed by EC although these cells made up 20% of
the cells in the enriched CM group on day 7 in culture
(figure 4(E)).
The vascular cords in the sequential preculture organoids
did not have open lumens. In vivo, sprouting angiogenesis
occurs by tip cell proliferation, migration and cord formation,
followed by lumen formation through vacuole propagation
(Fantin et al 2010, Wang et al 2010, Kamei et al 2006,
Lubarsky and Krasnow 2003). In this study the last stage
vacuole propagation and lumen formation was not yet
achieved.
No cord formation was observed at all at EC densities of
15% and 31%. At higher densities, EC monolayer formation
was observed. One possible explanation for formation of cords
in 8% EC group could be secretion of autocrine growth factors
(e.g. VEGF), which at the given cell density could be present
at such concentration to promote cord formation rather than
proliferation alone. One limitation of this study is that we
could not determine the exact number of EC in the 8% group
participating in the sprouting process, nor did we test a lower
EC seeding density than 8%.
Cell tri-culture is now commonly used to pre-vascularize
engineered cardiac tissues in vitro. Asakawa et al (2010)
created an in vitro pre-vascular network by co-culturing
ECs between cell sheets that were stacked to form three-
dimensional tissues. In another example using hESC-derived
CMs, Murry and colleagues (Stevens et al 2009a, 2009b)
created scaffold-less tissues, and Levenberg and colleagues
(Caspi et al 2007, Lesman et al 2010) created tissues on
porous scaffolds using CMs, ECs and mesenchymal cells
such as FBs. Their work collectively points to the fact that
integration of the engineered cardiac tissue with the host
myocardium was enhanced in the case of tri-culture (Iyer
et al 2009b, Lesman et al 2010). In those cases, the primitive
vessels in the engineered tissue functionally integrated with
the host coronary vasculature and enabled graft survival.
Recent evidence suggests that these randomly distributed
capillary-like structures anastomose with the host vasculature
through wrapping and tapping anastomosis, where the implant
vasculature wraps around the host vasculature, followed by
basement membrane dissolution and connection of the implant
endothelium to the host endothelium (Cheng et al 2011).
Human MSCs from the bone marrow were demonstrated to be
instrumental in stabilizing the engineered blood vessels giving
rise to perivascular cells (Au et al 2008). The work presented
here addresses the in vitro component of pre-vascularization
and demonstrates that the sequential seeding is beneficial for
cord formation and stabilization. Achieving a more organized
vascular structure in vitro is critical for the efficient vascular
integration in vivo (Koffler et al 2011).
Still, much remains to be investigated—that is, while
preculture of ECs and FBs prior to CMs has improved
the structure and function of engineered cardiac tissue, the
underlying mechanisms are yet to be explored. A combination
of soluble factors, secreted by the FBs and ECs during the
preculture period, as well as ECM deposited by these cells,
may be responsible for the improved survival and function
of CMs. Future work will be focused on identifying these
soluble factors and their downstream targets in order to further
elucidate the mechanisms at play.
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4. Summary
Sequential preculture of ECs was investigated in an attempt
to improve formation of vascular-like precursors known as
cords. By fixing the seeding percentage of CMs at 60%
and sequentially adding ECs, FBs (24 h later) and CMs
(48 h later), and modulating the percentage of ECs (8%,
15% and 31% of the total cell number), capillary cords
were found to form within 24 h only at the lowest seeding
percentage of 8%. The 8% EC group eventually developed
into functional cardiac organoids with ET comparable to
organoids engineered using CMs and the whole heart cell
isolates. The higher percentages (15% EC and 31% EC) groups
showed evidence of EC overgrowth and the formation of flat
EC monolayers, resulting in cardiac organoids with inferior
morphology and functional properties. The viability decreased
with an increasing EC density. Morphological similarities
and similar final percentages of CMs were noted between
the 8% EC group and the whole heart cell isolate group,
suggesting that the 8% EC group may be optimal for achieving
a cellular composition physiologically similar to that of the
native heart. Thus, sequential preculture with 8% ECs may
aid in engineering heart tissues that not only emulate the
electrophysiological properties of the native myocardium,
but also enhance the vascularization potential of the
tissue.
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